Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Chlorhexidine versus saline in reducing the risk of catheter associated urinary tract infection: A cost-effectiveness analysis.

Mitchell BG, Fasugba O, Cheng AC, Gregory V, Koerner J, Collignon P, Gardner A, Graves N.

Int J Nurs Stud. 2019 Sep;97:1-6. doi: 10.1016/j.ijnurstu.2019.04.003. Epub 2019 Apr 13.

2.

Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial.

Fasugba O, Cheng AC, Gregory V, Graves N, Koerner J, Collignon P, Gardner A, Mitchell BG.

Lancet Infect Dis. 2019 Jun;19(6):611-619. doi: 10.1016/S1473-3099(18)30736-9. Epub 2019 Apr 12.

PMID:
30987814
3.

An Investigation of Comorbid Disease and Health Service Utilization Among Patients With Moderate to Severe Psoriasis in Newfoundland and Labrador.

Gulliver WP, Randell S, Gulliver S, Macdonald D, Gregory V, Nagle S, Chambenoit O.

J Cutan Med Surg. 2019 Jan/Feb;23(1):29-34. doi: 10.1177/1203475418791114. Epub 2018 Jul 24.

PMID:
30041544
4.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.

Lackenby A, Besselaar TG, Daniels RS, Fry A, Gregory V, Gubareva LV, Huang W, Hurt AC, Leang SK, Lee RTC, Lo J, Lollis L, Maurer-Stroh S, Odagiri T, Pereyaslov D, Takashita E, Wang D, Zhang W, Meijer A.

Antiviral Res. 2018 Sep;157:38-46. doi: 10.1016/j.antiviral.2018.07.001. Epub 2018 Jul 3.

5.

Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.

Gulliver WP, Randell S, Gulliver S, Gregory V, Nagle S, Chambenoit O.

J Cutan Med Surg. 2018 Nov/Dec;22(6):567-576. doi: 10.1177/1203475418786712. Epub 2018 Jun 28.

PMID:
29952225
6.

Reducing catheter-associated urinary tract infections in hospitals: study protocol for a multi-site randomised controlled study.

Mitchell BG, Fasugba O, Gardner A, Koerner J, Collignon P, Cheng AC, Graves N, Morey P, Gregory V.

BMJ Open. 2017 Nov 28;7(11):e018871. doi: 10.1136/bmjopen-2017-018871.

7.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Gubareva LV, Besselaar TG, Daniels RS, Fry A, Gregory V, Huang W, Hurt AC, Jorquera PA, Lackenby A, Leang SK, Lo J, Pereyaslov D, Rebelo-de-Andrade H, Siqueira MM, Takashita E, Odagiri T, Wang D, Zhang W, Meijer A.

Antiviral Res. 2017 Oct;146:12-20. doi: 10.1016/j.antiviral.2017.08.004. Epub 2017 Aug 10.

8.

Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season.

Korsun N, Angelova S, Gregory V, Daniels R, Georgieva I, McCauley J.

Infect Genet Evol. 2017 Apr;49:241-250. doi: 10.1016/j.meegid.2017.01.027. Epub 2017 Jan 27.

9.

Identification of Low- and High-Impact Hemagglutinin Amino Acid Substitutions That Drive Antigenic Drift of Influenza A(H1N1) Viruses.

Harvey WT, Benton DJ, Gregory V, Hall JP, Daniels RS, Bedford T, Haydon DT, Hay AJ, McCauley JW, Reeve R.

PLoS Pathog. 2016 Apr 8;12(4):e1005526. doi: 10.1371/journal.ppat.1005526. eCollection 2016 Apr.

10.

Impact de la graisse adhérente péri-rénale sur les résultats péri-opératoires de la néphrectomie partielle robot-assistée.

Khene Z, Peyronnet B, Mathieu R, Fardoun T, Grégory V, Bensalah K.

Prog Urol. 2015 Nov;25(13):745. doi: 10.1016/j.purol.2015.08.059. French. No abstract available.

PMID:
26544255
11.

Influenza virus surveillance in Argentina during the 2012 season: antigenic characterization, genetic analysis and antiviral susceptibility.

Benedetti E, Daniels RS, Pontoriero A, Russo M, Avaro M, Czech A, Campos A, Periolo N, Gregory V, McCauley JW, Baumeister EG.

Epidemiol Infect. 2016 Mar;144(4):751-67. doi: 10.1017/S0950268815001806. Epub 2015 Sep 8.

12.

Discovery of oxathiapiprolin, a new oomycete fungicide that targets an oxysterol binding protein.

Pasteris RJ, Hanagan MA, Bisaha JJ, Finkelstein BL, Hoffman LE, Gregory V, Andreassi JL, Sweigard JA, Klyashchitsky BA, Henry YT, Berger RA.

Bioorg Med Chem. 2016 Feb 1;24(3):354-61. doi: 10.1016/j.bmc.2015.07.064. Epub 2015 Jul 31.

PMID:
26314923
13.

Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses.

Lin Y, Gu Y, Wharton SA, Whittaker L, Gregory V, Li X, Metin S, Cattle N, Daniels RS, Hay AJ, McCauley JW.

Influenza Other Respir Viruses. 2015 Nov;9(6):331-340. doi: 10.1111/irv.12333.

14.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M.

Antiviral Res. 2015 May;117:27-38. doi: 10.1016/j.antiviral.2015.02.003. Epub 2015 Feb 23.

15.

Beliefs about research and social work practice: a systematic psychometric review of scales.

Gregory VL Jr.

J Evid Inf Soc Work. 2015;12(2):237-59. Epub 2015 Feb 3. Review.

PMID:
25661901
16.

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

Meijer A, Rebelo-de-Andrade H, Correia V, Besselaar T, Drager-Dayal R, Fry A, Gregory V, Gubareva L, Kageyama T, Lackenby A, Lo J, Odagiri T, Pereyaslov D, Siqueira MM, Takashita E, Tashiro M, Wang D, Wong S, Zhang W, Daniels RS, Hurt AC.

Antiviral Res. 2014 Oct;110:31-41. doi: 10.1016/j.antiviral.2014.07.001. Epub 2014 Jul 17.

17.

Cluster of influenza A cases in vaccinated population of adults in Virology Laboratory in Glasgow in December 2012.

Bradley-Stewart A, Miller RS, Maclean A, Aitken C, Whittaker L, Gregory V, Daniels R, Gunson R.

Scott Med J. 2014 May;59(2):95-102. doi: 10.1177/0036933014529057. Epub 2014 Mar 21.

PMID:
24659378
18.

Integrating influenza antigenic dynamics with molecular evolution.

Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A.

Elife. 2014;3:e01914. doi: 10.7554/eLife.01914. Epub 2014 Feb 4.

19.

Sentinel surveillance for influenza in Senegal, 1996-2009.

Niang MN, Dosseh A, Ndiaye K, Sagna M, Gregory V, Goudiaby D, Hay A, Diop OM.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S129-35. doi: 10.1093/infdis/jis576.

PMID:
23169958
20.

Gregory research beliefs scale: discriminant construct, concurrent criterion, and known-groups validity.

Gregory VL Jr.

J Evid Based Soc Work. 2012;9(5):465-80. doi: 10.1080/15433714.2011.561130.

PMID:
23092376
21.

Addressing the nutritional needs of older people in residential care homes.

Merrell J, Philpin S, Warring J, Hobby D, Gregory V.

Health Soc Care Community. 2012 Mar;20(2):208-15. doi: 10.1111/j.1365-2524.2011.01033.x. Epub 2011 Oct 11.

PMID:
21985114
22.

Sociocultural context of nutrition in care homes.

Philpin S, Merrell J, Warring J, Gregory V, Hobby D.

Nurs Older People. 2011 May;23(4):24-30.

PMID:
21675166
23.

Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus.

Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, Daniels R, Gregory V, Uhlendorff J, Kiso M, Klenk HD, Hay A, Feizi T, Matrosovich M.

J Virol. 2010 Nov;84(22):12069-74. doi: 10.1128/JVI.01639-10. Epub 2010 Sep 8.

24.

Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.

Yavarian J, Azad TM, Zheng X, Gregory V, Lin YP, Hay A.

Antiviral Res. 2010 Nov;88(2):193-6. doi: 10.1016/j.antiviral.2010.08.013. Epub 2010 Sep 9.

PMID:
20816700
25.

Cognitive-behavioral therapy for depression in bipolar disorder: a meta-analysis.

Gregory VL Jr.

J Evid Based Soc Work. 2010 Jul;7(4):269-79. doi: 10.1080/15433710903176088.

PMID:
20799127
26.

Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?

Lin YP, Gregory V, Collins P, Kloess J, Wharton S, Cattle N, Lackenby A, Daniels R, Hay A.

J Virol. 2010 Jul;84(13):6769-81. doi: 10.1128/JVI.00458-10. Epub 2010 Apr 21.

27.

Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.

Njouom R, Mba SA, Noah DN, Gregory V, Collins P, Cappy P, Hay A, Rousset D.

BMC Infect Dis. 2010 Mar 8;10:56. doi: 10.1186/1471-2334-10-56.

28.

Structural basis for oseltamivir resistance of influenza viruses.

Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Martin SR, Daniels RS, Gregory V, Skehel JJ, Gamblin SJ, Hay AJ.

Vaccine. 2009 Oct 23;27(45):6317-23. doi: 10.1016/j.vaccine.2009.07.017.

PMID:
19840667
29.

A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance.

Hann HW, Gregory VL, Dixon JS, Barker KF.

Hepatol Int. 2008 Dec;2(4):440-56. doi: 10.1007/s12072-008-9105-y. Epub 2008 Oct 21.

30.

Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007-2008 winter season in Luxembourg: clinical characteristics and epidemiology.

Mossong J, Opp M, Gerloff N, Hau P, Kremer J, Lackenby A, Gregory V, Even J, Huberty-Krau P, Muller CP, Schneider F.

Antiviral Res. 2009 Oct;84(1):91-4. doi: 10.1016/j.antiviral.2009.08.001. Epub 2009 Aug 7.

PMID:
19665488
31.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. Review.

PMID:
19230156
32.

Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.

Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney J, Manamela JM, Blumberg L, Schoub BD.

Emerg Infect Dis. 2008 Nov;14(11):1809-10. doi: 10.3201/eid1411.080958. No abstract available.

33.

The global circulation of seasonal influenza A (H3N2) viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Science. 2008 Apr 18;320(5874):340-6. doi: 10.1126/science.1154137.

34.

Influenza virus infection in travelers to tropical and subtropical countries.

Mutsch M, Tavernini M, Marx A, Gregory V, Lin YP, Hay AJ, Tschopp A, Steffen R.

Clin Infect Dis. 2005 May 1;40(9):1282-7. Epub 2005 Mar 28.

35.

Changes in the hemagglutinins and neuraminidases of human influenza B viruses isolated in Italy during the 2001-02, 2002-03, and 2003-04 seasons.

Puzelli S, Frezza F, Fabiani C, Ansaldi F, Campitelli L, Lin YP, Gregory V, Bennett M, D'Agaro P, Campello C, Crovari P, Hay A, Donatelli I.

J Med Virol. 2004 Dec;74(4):629-40.

PMID:
15484280
36.

A summer outbreak of influenza A virus infection among young children.

Wolf DG, Rekhtman D, Kerem E, Hay A, Mador N, Greenbaum E, Dorozhko M, Gregory V, Lin YP, Zakay-Rones Z.

Clin Infect Dis. 2004 Aug 15;39(4):595-7. Epub 2004 Jul 28.

PMID:
15356830
37.

Recent changes among human influenza viruses.

Lin YP, Gregory V, Bennett M, Hay A.

Virus Res. 2004 Jul;103(1-2):47-52. Review.

PMID:
15163487
38.

Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.

Ansaldi F, D'Agaro P, De Florentiis D, Puzelli S, Lin YP, Gregory V, Bennett M, Donatelli I, Gasparini R, Crovari P, Hay A, Campello C.

J Med Virol. 2003 Jul;70(3):463-9.

PMID:
12767012
39.

Human infection by a swine influenza A (H1N1) virus in Switzerland.

Gregory V, Bennett M, Thomas Y, Kaiser L, Wunderli W, Matter H, Hay A, Lin YP.

Arch Virol. 2003 Apr;148(4):793-802.

PMID:
12664301
40.

Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season.

Ellis JS, Alvarez-Aguero A, Gregory V, Lin YP, Hay A, Zambon MC.

Emerg Infect Dis. 2003 Mar;9(3):304-10.

41.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
42.

Emergence of influenza A H1N2 reassortant viruses in the human population during 2001.

Gregory V, Bennett M, Orkhan MH, Al Hajjar S, Varsano N, Mendelson E, Zambon M, Ellis J, Hay A, Lin YP.

Virology. 2002 Aug 15;300(1):1-7.

43.

Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe.

Marozin S, Gregory V, Cameron K, Bennett M, Valette M, Aymard M, Foni E, Barigazzi G, Lin Y, Hay A.

J Gen Virol. 2002 Apr;83(Pt 4):735-45.

PMID:
11907321
44.

The evolution of human influenza viruses.

Hay AJ, Gregory V, Douglas AR, Lin YP.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70. Review.

45.

Rapid molecular analysis of the haemagglutinin gene of human influenza A H3N2 viruses isolated in spain from 1996 to 2000.

Coiras MT, Aguilar JC, Galiano M, Carlos S, Gregory V, Lin YP, Hay A, Pérez-Breña P.

Arch Virol. 2001;146(11):2133-47.

PMID:
11765916
46.

Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs.

Gregory V, Lim W, Cameron K, Bennett M, Marozin S, Klimov A, Hall H, Cox N, Hay A, Lin YP.

J Gen Virol. 2001 Jun;82(Pt 6):1397-406.

PMID:
11369884
47.

H9N2 subtype influenza A viruses in poultry in pakistan are closely related to the H9N2 viruses responsible for human infection in Hong Kong.

Cameron KR, Gregory V, Banks J, Brown IH, Alexander DJ, Hay AJ, Lin YP.

Virology. 2000 Dec 5;278(1):36-41.

48.

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

Lin YP, Shaw M, Gregory V, Cameron K, Lim W, Klimov A, Subbarao K, Guan Y, Krauss S, Shortridge K, Webster R, Cox N, Hay A.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9654-8.

49.

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.

Bender C, Hall H, Huang J, Klimov A, Cox N, Hay A, Gregory V, Cameron K, Lim W, Subbarao K.

Virology. 1999 Feb 1;254(1):115-23.

50.

Factors influencing utilization of postdischarge cognitive rehabilitation programs.

Gummow LJ, Gregory VR, Macnamara SE.

Health Serv Res. 1990 Apr;25(1 Pt 2):197-211.

Supplemental Content

Loading ...
Support Center